PHPMem v2.0.1
Version
1.6.45
Uptime
15 days 12 hours 53 minutes 49 seconds
Memory
Total
512MB
Used
9,60MB (1.88%)
Free
502,40MB
Keys
Current
11 839
Total (since start)
35 066
Evictions
0
Reclaimed
734
Expired Unfetched
0
Evicted Unfetched
0
Connections
Current
14 / 1 024 max
Total
174 052
Rejected
0
llm:041616f34755fefc18900bab3c36529fa77e0660e277259393dacce5dd84217b
Edit
```json
{
"proposals": [
{
"join_class": "temporal",
"column": "ae.AEDTC",
"kind": "external_candidate",
"entry_id": null,
"name": "FDA Drug Approval Dates",
"probable_url": "https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files",
"license_expectation": "Public Domain (US Government)",
"join_story": "Joining adverse event dates to FDA approval timelines would reveal whether events cluster in early post-approval periods versus mature drug lifecycles, helping distinguish launch-phase surveillance signals from long-term safety patterns.",
"teaches": "Whether your adverse events concentrate in newly approved drugs or established therapies, informing risk monitoring priorities."
},
{
"join_class": "category",
"column": "ae.AEACN",
"kind": "external_candidate",
"entry_id": null,
"name": "MedDRA Hierarchy Reference",
"probable_url": "https://www.meddra.org/how-to-use/support-documentation/english",
"license_expectation": "Restricted - requires subscription",
"join_story": null,
"teaches": null
}
]
}
```
Wait, I need to reconsider. MedDRA requires subscription access, which violates the "public, credential-free" requirement. Let me revise:
```json
{
"proposals": [
{
"join_class": "temporal",
"column": "ae.AEDTC",
"kind": "external_candidate",
"entry_id": null,
"name": "FDA Drug Approval Dates",
"probable_url": "https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files",
"license_expectation": "Public Domain (US Government)",
"join_story": "Joining adverse event dates to FDA approval timelines would reveal whether events cluster in early post-approval periods versus mature drug lifecycles, helping distinguish launch-phase surveillance signals from long-term safety patterns.",
"teaches": "Whether your adverse events concentrate in newly approved drugs or established therapies, informing risk monitoring priorities."
}
]
}
```